SCHEMBL7470229

SCHEMBL7470229

COc1ccc(C(=O)c2ccccc2)c(SC(=O)N(C)C)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.60
LMNA P02545 4/20 0.58
ALDH1A1 P00352 4/20 0.58
CYP1A2 P05177 4/20 0.58
HTT P42858 4/20 0.58
CYP2C19 P33261 3/20 0.58
MAPK1 P28482 3/20 0.58
PGR P06401 2/20 0.58
HPGD P15428 2/20 0.58
SLC6A2 P23975 2/20 0.58
CYP2D6 P10635 1/20 0.58
PDE4A P27815 1/20 0.58
HRH1 P35367 1/20 0.58
SLC6A3 Q01959 1/20 0.58
PDE4D Q08499 1/20 0.58
KMT2A Q03164 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
RAB9A P51151 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
TSHR P16473 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4427093 0.91 POLB (0.50) POLBLMNAALDH1A1CYP1A2HTT
SCHEMBL11761193 0.82 ALDH1A1 (0.66) POLBLMNAALDH1A1CYP1A2HTT
SCHEMBL9575469 0.80 AKR1C3 (0.47) POLBALDH1A1HPGDKMT2ARAB9A
SCHEMBL29587928 0.76 LMNA (0.66) POLBLMNAALDH1A1CYP1A2HTT
SCHEMBL3605144 0.75 NCEH1 (0.39) POLBLMNAALDH1A1CYP1A2CYP2C19
SCHEMBL348831 0.74 NPC1 (0.45) POLBLMNAALDH1A1CYP1A2HTT
SCHEMBL2945284 0.74 CYP1A2 (0.71) POLBLMNAALDH1A1CYP1A2HTT
SCHEMBL3480945 0.74 ALDH1A1 (0.71) POLBLMNAALDH1A1CYP1A2HTT
Oxybenzone SCHEMBL15551 0.74 HPGD (1.00) POLBLMNAALDH1A1CYP1A2HTT
SCHEMBL3224251 0.74 NPC1 (0.81) POLBLMNAALDH1A1CYP1A2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0775126-B1 HYPOLIPIDEMIC 1,4-BENZOTHIAZEPINE-1,1-DIOXIDES WELLCOME FOUND (GB) 2002-10-30 EP disclosed
EP-0683774-B1 HYPOLIPIDAEMIC COMPOUNDS WELLCOME FOUND (GB) 2002-10-09 EP disclosed
EP-1203769-A1 Hypolipidemic 1,4-benzothiazepine derivative THE WELLCOME FOUNDATION LIMITED (GB) 2002-05-08 EP disclosed
US-5910494-A NOVEL COMPOUNDS THAT REDUCE THE ABSORPTION OF BILE ACIDS FROM THE INTESTINE; FOR PROPHYLAXIS AND TREATMENT OF HYPERLIPIDEMIC CONDITIONS, SUCH AS ATHEROSCLEROSIS GLAXO WELLCOME INC. (US) 1999-06-08 US disclosed
WO-1998038182-A9 HYPOLIPIDEMIC BICYCLIC DERIVATIVES GLAXO GROUP LTD (GB) 1999-04-15 WO disclosed
US-5817652-A ATHEROSCLEROSIS GLAXO WELLCOME INC. (US) 1998-10-06 US disclosed
WO-1998038182-A1 HYPOLIPIDEMIC BICYCLIC DERIVATIVES GLAXO GROUP LIMITED (GB) 1998-09-03 WO disclosed
US-5723458-A 1,4-BENZOTHIAZEPINES GLAXO WELLCOME INC. (US) 1998-03-03 US disclosed
EP-0683773-B1 HYPOLIPIDAEMIC CONDENSED 1,4-THIAZEPINES WELLCOME FOUND (GB) 1997-09-17 EP disclosed
WO-1994018184-A1 HYPOLIPIDAEMIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1994-08-18 WO disclosed
WO-1994018183-A1 HYPOLIPIDAEMIC CONDENSED 1,4-THIAZEPINES THE WELLCOME FOUNDATION LIMITED (GB) 1994-08-18 WO disclosed